FanDuel and Gronk’s Kick of Destiny Super Bowl Promotion
Think you can bet on Gronk to make (or miss) a field goal? Think again.
Vioxx
In August 2013, a federal judge preliminarily approved a $23 million settlement to a class-action lawsuit filed against Merck Sharp & Dohme Corp. for allegedly falsely advertising that Vioxx had greater benefits than the generic versions when these benefits had not been established. According to the settlement terms, class members may receive a cash award of up to $75 with proof of purchase. (In re: Vioxx Products Liability Litigation, MDL No. 1657, E. D. LA.).
The Latest
FTC Must Stem Tide of Junk Fees Pandemic
TINA.org submits comment regarding the need for a commission rule.
Lume Deodorant’s ‘Aluminum-Free,’ ‘Clinically Proven’ Odor Control Claims
Consumers should sweat these claims.
Correct The Internet
Tackling gender bias in search.
Crash Proof Retirement’s ‘Inflation Fighters’
TINA.org takes a closer look at company’s claims of ‘guaranteed income.’